Anthem Biosciences Ltd
NSE: ANTHEM BSE: 544449
₹769.10
(1.46%)
Tue, 26 May 2026, 06:26 pm
Market Cap438.28B
PE Ratio73.54
Dividend0
Health Technology
Biotechnology
24.5KAnthem Biosciences Cashflow
| Particulars | 2021 | 2022 | 2023 |
|---|---|---|---|
| Deprecation and amortization | -577.56M | -636.96M | -818.24M |
| Accumulated depreciation, total | -3.62B | -4.20B | -4.94B |
| Cash from operating activities | 3.42B | 3.43B | 1.79B |
| Funds from operations | 4.81B | 4.47B | 4.41B |
| Net income (cash flow) | 4.06B | 3.85B | 3.67B |
| Depreciation & amortization (cash flow) | 578.35M | 637.74M | 818.24M |
| Depreciation/depletion | 551.77M | 603.47M | 781.23M |
| Amortization | 26.58M | 34.27M | 37.01M |
| Deferred taxes (cash flow) | 0 | 0 | 0 |
| Non-cash items | -1.23B | -1.14B | -1.19B |
| Changes in working capital | -1.39B | -1.04B | -2.62B |
| Cash from investing activities | -2.24B | -4.20B | -2.69B |
| Capital expenditures | -1.61B | -1.95B | -2.97B |
| Capital expenditures - fixed assets | -1.58B | -1.89B | -2.96B |
| Capital expenditures - other assets | -31.39M | -56.17M | -8.55M |
| Cash from financing activities | 1.91B | 706.59M | -676.46M |
| Free cash flow | 1.84B | 1.54B | -1.18B |